Asthma: Clinical Trials

4,547 trials for Asthma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3128 completed, 499 unknown, 295 recruiting, 241 terminated. 1208 Not applicable, 679 Phase 2, 615 Phase 3, 442 Phase 4, 403 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1208Completed 780, Unknown 177, Recruiting 87, Not yet recruiting 48, Terminated 43, Withdrawn 40, Active not recruiting 23, Enrolling by invitation 6, Suspended 4
Phase 2679Completed 491, Terminated 57, Withdrawn 41, Recruiting 35, Unknown 31, Active not recruiting 15, Not yet recruiting 7, Enrolling by invitation 2
Phase 3615Completed 481, Terminated 34, Recruiting 33, Unknown 28, Withdrawn 22, Active not recruiting 9, Not yet recruiting 6, Enrolling by invitation 1, Suspended 1
Phase 4442Completed 313, Unknown 47, Terminated 37, Recruiting 17, Withdrawn 11, Active not recruiting 10, Not yet recruiting 5, Enrolling by invitation 2
Phase 1403Completed 314, Terminated 32, Unknown 16, Recruiting 15, Withdrawn 15, Active not recruiting 6, Not yet recruiting 5
Early Phase 125Completed 16, Terminated 4, Active not recruiting 2, Enrolling by invitation 1, Recruiting 1, Unknown 1

Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function
Phase 2Not yet recruitingForesee Pharmaceuticals Co., Ltd.1352027-03-012026-07-20
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
HDM sublingual Immunotherapy, Placebo - Asthma, Allergy
Phase 2WithdrawnBoston Children's Hospital2027-02-012024-11-26
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies
Initial assesment interwiew, Intake Interview with the Patient - Severe Asthma
Not yet recruitingUniversity Hospital, Angers202027-01-042026-10-02
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Slow Release DHEA, Placebo - Asthma
Phase 2Not yet recruitingIndiana University302027-01-012026-02-27
Nebulized Ketamine for Severe Asthma Attacks in Children
Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma
Phase 2Not yet recruitingSultan Qaboos University602027-01-012026-07-27
Sustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)
Comprehensive Biomarker-Guided Management Strategy, Standard of Care - Asthma (Diagnosis)
Not applicableNot yet recruitingHana Serajeddini502026-12-022026-09-25
Development and Validation of the Indian Asthma Care Bundle for Reducing Readmission and Improving Post-hospitalisation Care After Discharge From Hospital Due to an Acute Asthma Exacerbation
Indian Asthma Care Bundle (I-ACB) - Asthma Exacerbation, Asthma (Diagnosis)
Not applicableNot yet recruitingAhmedabad University2602026-12-012026-09-11
Study of HXN-1013 in Healthy Participants and Participants With Mild-to-Moderate Asthma
HXN-1013, Placebo - Health Adults, Asthma
Phase 1Not yet recruitingHelixon Biotechnology (Suzhou) Co., Ltd402026-12-012026-10-28
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)
Not yet recruitingAstraZeneca2102026-11-282026-06-04
Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
CHF5993 100/6/12.5 μg pMDI HFA-152a, Seretide Evohaler - Asthma
Phase 3Not yet recruitingChiesi Farmaceutici S.p.A.7002026-11-162026-10-05
Changing Lifestyle to Improve Quality of Life in Spanish Adolescents With Asthma
Lifestyle-change intervention - Asthma (Diagnosis)
Not applicableNot yet recruitingUniversitat Internacional de Catalunya962026-11-022026-10-22
R34 Asthma Depression
SAMBA, Cognitive Behavioral Therapy-Asthma Depression (CBT-AD), Original SAMBA - Asthma, Depression
Not applicableNot yet recruitingIcahn School of Medicine at Mount Sinai602026-11-012026-10-26
Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease
1MSTS - COPD (Chronic Obstructive Pulmonary Disease), Asthma (Diagnosis)
Not yet recruitingJacob Sandberg1202026-11-012026-09-23
Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)
Anakinra 100 Mg/0.67 Ml Inj Syringe, Saline Placebo/0.67 Ml Inj Syringe - Asthma (Diagnosis), Persistent Asthma
Phase 1Not yet recruitingUniversity of North Carolina, Chapel Hill602026-11-012026-07-15
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma
Phase 4Not yet recruitingUniversity of Wisconsin, Madison202026-11-012026-09-24
Fatty Acids in Airway Smooth Muscle of Asthmatics
coconut oil - Asthma
Not applicableWithdrawnBrigham and Women's Hospital2026-11-012024-10-23
Ginger's Therapeutic Potential in Asthma
Ginger Extract, Placebo - Asthma
Phase 2Not yet recruitingEmily DiMango, MD322026-11-012026-08-28
Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University Hospital
Allergic Diseases in Nephrotic Children, Nephrotic Syndrom
Not yet recruitingSohag University202026-11-012026-10-27
Reducing Exposure With Air Cleaners and Technology
Air Cleaner, PM2.5 Monitor with Visual Air Quality Indicator, Educational Materials - Asthma, COPD (Chronic Obstructive Pulmonary Disease)
Not applicableNot yet recruitingUniversity of California, Berkeley1002026-11-012026-11-03

Showing 20 of 4547. Sign in to see all of them.

Narrower conditions

Pulmonary Disease, Chronic Obstructive (443)  ·  Hypersensitivity (186)  ·  Lung Diseases (148)  ·  Rhinitis, Allergic (122)  ·  Obesity (91)  ·  Disease (84)  ·  Inflammation (74)  ·  Respiratory Sounds (73)  ·  Heart Failure (68)  ·  Diabetes Mellitus (67)  ·  Dyspnea (67)  ·  Hypertension (59)  ·  Pulmonary Eosinophilia (57)  ·  Asthma, Exercise-Induced (52)

Broader conditions

Hypersensitivity, Immediate (4530)  ·  Immune System Diseases (4530)  ·  Bronchial Diseases (4511)  ·  Respiratory Hypersensitivity (4509)  ·  Respiratory Tract Diseases (4495)  ·  Lung Diseases, Obstructive (4433)  ·  Hypersensitivity (4361)  ·  Lung Diseases (4336)  ·  Pathological Conditions, Signs and Symptoms (938)  ·  Pathologic Processes (666)  ·  Disease Attributes (501)  ·  Chronic Disease (445)  ·  Signs and Symptoms (307)  ·  Infections (224)  ·  Otorhinolaryngologic Diseases (222)

Interventions

Budesonide (172)  ·  Fluticasone (164)  ·  Albuterol (157)  ·  montelukast (144)  ·  Formoterol Fumarate (105)  ·  Fluticasone-Salmeterol Drug Combination (85)  ·  Budesonide, Formoterol Fumarate Drug Combination (79)  ·  Salmeterol Xinafoate (78)  ·  Beclomethasone (73)  ·  Omalizumab (67)  ·  benralizumab (49)  ·  mepolizumab (49)  ·  fluticasone furoate (41)  ·  Mometasone Furoate (40)  ·  dupilumab (40)

Sponsors

AstraZeneca (314)  ·  GlaxoSmithKline (262)  ·  National Heart, Lung, and Blood Institute (NHLBI) (76)  ·  Novartis Pharmaceuticals (73)  ·  Organon and Co (66)  ·  Boehringer Ingelheim (62)  ·  Chiesi Farmaceutici S.p.A. (62)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (45)  ·  Imperial College London (43)  ·  Brigham and Women's Hospital (41)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (39)  ·  Sanofi (37)  ·  University of California, San Francisco (34)  ·  National Institute of Environmental Health Sciences (NIEHS) (31)  ·  Johns Hopkins University (30)

Countries

United States (1615)  ·  United Kingdom (526)  ·  Canada (414)  ·  Germany (369)  ·  France (277)  ·  Poland (249)  ·  China (228)  ·  Spain (210)  ·  Italy (170)  ·  Netherlands (152)  ·  Russia (152)  ·  Argentina (146)  ·  Hungary (139)  ·  Brazil (137)  ·  South Korea (135)

Top investigators

Louis-Philippe Boulet, MD (20)  ·  Elliot Israel, MD (15)  ·  Catherine Bonuccelli (11)  ·  Dave Singh, MD (9)

Results publications

PMID 36472162, PMID 27881132, PMID 39393433, PMID 31319851, PMID 29400693, PMID 35691614, PMID 33217063, PMID 38127464, PMID 26704701, PMID 30954640, PMID 22329608, PMID 24184147, PMID 28065396, PMID 29174062, PMID 29536781, PMID 32180164, PMID 33305842, PMID 34098955, PMID 35636689, PMID 10573240, PMID 14713908, PMID 20075384, PMID 20851928, PMID 21060320, PMID 24838406, PMID 24966061, PMID 26369589, PMID 26498386, PMID 26612545, PMID 30802500, PMID 30876830, PMID 31047111, PMID 31251094, PMID 31447130, PMID 31613151, PMID 31760132, PMID 31798645, PMID 32298853, PMID 33223095, PMID 33369570, PMID 33465457, PMID 33710614, PMID 35287231, PMID 36253275, PMID 36356712, PMID 36702146, PMID 37431558, PMID 37536444, PMID 39309477, PMID 41314665

NIH funding

2015 (27), 2016 (27), 2009 (22), 2014 (22), 2017 (17), 2018 (17), 2023 (17), 2019 (15), 2025 (14), 2008 (11), U10HL098115 (8), U10HL074212 (6), P01HL107202 (5), R01HL135235 (5), U10HL064287 (5)